Cardiff Oncology Inc
Research Cardiff Oncology Inc (CRDF) on Bullrun: market cap USD 86.83M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCRDF
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 86.83M
- Financial periodFY2025
- RevenueUSD 593.00K
- Revenue growth-13.2%
- Net income-USD 45.85K
- Free cash flow-USD 37.97M
Valuation Snapshot
latest market cap is USD 86.83M.
About Cardiff Oncology Inc
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer.
Frequently asked questions
What is Cardiff Oncology Inc's market cap?
Cardiff Oncology Inc's market capitalization is USD 86.83M.
What does Cardiff Oncology Inc do?
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer.